Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Clinical and Vaccine Immunology : CVI|March 14, 2008
Prevention of assay interference in infectious-disease serology tests done on the liaison platformMario Berth, Eugene Bosmans
Clinical and Vaccine Immunology : CVI|February 12, 2010
Comparison of three automated immunoassay methods for the determination of Epstein-Barr virus-specific immunoglobulin MMario Berth, Eugene Bosmans
Diagnostic Microbiology and Infectious Disease|June 15, 2019
Evaluation of the VIDAS hepatitis E IgM test in a nonendemic regionMercedeh Tajdar, Marijke Reynders, Mario Berth
Clinical Chemistry and Laboratory Medicine|March 12, 2014
Sigma metrics used to assess analytical quality of clinical chemistry assays: importance of the allowable total error (TEa) targetKoen Hens, Mario Berth, Dave Armbruster, et al.
Clinical Chemistry and Laboratory Medicine|November 30, 2019
Interference of anti-streptavidin antibodies in immunoassays: a very rare phenomenon or a more common finding?Nick Verougstraete, Mario Berth, Mario Vaneechoutte, et al.
Diagnostic Microbiology and Infectious Disease|May 10, 2014
Comparative evaluation of the new ARCHITECT EBV assays considering different testing algorithmsEva Sickinger, Mario Berth, Angela Vockel, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 28, 2012
Re-evaluation of the VIDAS(®) cytomegalovirus (CMV) IgG avidity assay: determination of new cut-off values based on the study of kinetics of CMV-IgG maturationChristelle Vauloup-Fellous, Mario Berth, Fabienne Heskia, et al.
Pageof 3